Clinical Trials on Fructose Metabolism Disorder

Total 160860 results

University of Leeds

Completed

Effects of Polyphenols Found in Pomegranate Juice on Postprandial Blood Glucose in Vivo

Hyperglycaemia

United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)

Dyslipidemia
Vanderbilt University Medical Center

Completed

Identification of Inpatients at Risk for Poor Glycemic Control

Hyperglycemia | Hypoglycemia

United States
Postgraduate Institute of Medical Education and...

Completed

Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy

Dyslipidemias

India
Azienda Ospedaliero-Universitaria di Parma
DOC generici srl

Completed

Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects (Coleosoma)

Dyslipidemias

Italy
Kuhnil Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled (ROMANTIC)

Dyslipidemias
Xention Ltd

Completed

ADME Study in Healthy Male Subjects With TA-8995

Dyslipidemia

United Kingdom
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis (ENTHRALL)

Dyslipidemias

United States
The Hospital for Sick Children

Completed

Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial

Dyslipidemias
University of Pennsylvania
Abbott

Completed

Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study (CENTAUR)

Dyslipidemia

United States
University of Leeds

Completed

Effects of Carbohydrase-inhibiting Polyphenols on Glycaemic Response in Vivo

Hyperglycaemia

United Kingdom
Merck Sharp & Dohme LLC

Completed

Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)

Dyslipidemia
Merck Sharp & Dohme LLC

Completed

Fenofibrate Bioequivalence Study (0767-031)

Dyslipidemia
University of Palermo

Completed

Bergamot and Cardio-Metabolic Risk Factors

Dyslipidemia

Italy
Merck Sharp & Dohme LLC

Completed

A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)

Dyslipidemia
Merck Sharp & Dohme LLC

Terminated

MK0354 Clinical Efficacy and Tolerability Study (0354-004)

Dyslipidemia
Merck Sharp & Dohme LLC

Terminated

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Dyslipidemia
University of Alberta
AstraZeneca

Completed

A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets (RxACT)

Dyslipidemias

Canada
Merck Sharp & Dohme LLC

Completed

A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)

Dyslipidemia
Merck Sharp & Dohme LLC

Withdrawn

Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)

Dyslipidemia
Maastricht University Medical Center
DSM Nutritional Products, Inc.

Completed

Resveratrol and Serum Apo A-I

Dyslipidemia

Netherlands
AstraZeneca
Fundació Institut Català de Farmacologia

Withdrawn

Observational Study To Evaluate Statins Patterns Of Use In Spain

Dyslipidemia

Spain
Catabasis Pharmaceuticals

Completed

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

Dyslipidemia

United States
Akros Pharma Inc.

Completed

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Dyslipidemia

United States
University of Virginia
University of Texas; U.S. Army Medical Research and Development Command

Unknown

Pilot Study of Intensive Care Unit Continuous Glucose Monitoring

Hyperglycemia | Hypoglycemia

United States
UCSF Benioff Children's Hospital Oakland
Dairy Management Inc.

Completed

Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL)

Dyslipidemia

United States
Bristol-Myers Squibb

Completed

Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia

Dyslipidemia

United States, Canada
MaiHealth Inc

Unknown

Longitudinal Study of Multi-Analyte Profile for Dyslipidemia

Dyslipidemia

United States
Indonesia University

Completed

Effect of Nigella Sativa on Lipid Profiles in Elderly

Dyslipidemia

Indonesia
AstraZeneca

Completed

Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

Dyslipidemia

Mexico
Enzymotec

Completed

Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels

Dyslipidemia

Israel
AstraZeneca

Completed

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESENDO)

Dyslipidemia

Korea, Republic of
Sheba Medical Center

Unknown

Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences

Iron Overload

Israel
Hospital de Clinicas de Porto Alegre

Completed

Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period

Dyslipidemia

Brazil
CHU de Quebec-Universite Laval
AstraZeneca

Completed

Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia

Dyslipidemia

Canada
Stanford University

Not yet recruiting

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness

Obesity | Metabolic Syndrome | Bipolar Disorder | Bipolar and Related Disorders | Bipolar Depression | Weight Gain | Bipolar I Disorder | Ketogenic Dieting | Bipolar Disorder I | Bipolar II Disorder | Psychotropic Agents Causing Adverse Effects in Therapeutic Use | Brain Metabolic Disorder | Bipolar Disorder, Type... and other conditions

United States
Kastle Therapeutics, LLC
Ionis Pharmaceuticals, Inc.

Completed

Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration

Metabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Lipid Metabolism, Inborn Errors | Hypobetalipoproteinemias | Hypolipoproteinemias | Hypolipopro... and other conditions

Netherlands
Dasman Diabetes Institute

Unknown

Metabolic Defects in Prediabetic Kuwaiti Arabs and Indians

Pathophysiology | Metabolic Glucose Disorders

Kuwait
Novo Nordisk A/S

Completed

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Terminated

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Obesity | Metabolism and Nutrition Disorder

United States
Atlas Biomed

Withdrawn

Dietary Fibers Effect on the Gut Microbiota Composition

Inflammation | Metabolic Syndrome | Dyslipidemias | Cardiovascular Risk Factor | Microbiome

Russian Federation
AstraZeneca
AstraZeneca K.K.

Recruiting

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia (PURSUIT)

Dyslipidemia

Denmark, Hungary, Spain, United States, Japan, Czechia, Slovakia, Canada
Yonsei University

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

Dyslipidemia

Korea, Republic of
Dongkwang Pharm. Co., Ltd.

Not yet recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Dyslipidemias
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

Dyslipidemias
Adrian Vella
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics

Healthy

United States
Hospices Civils de Lyon

Recruiting

From Known to New Genes in Dyslipidemia (GENELIP)

Dyslipidemias

France
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

Dyslipidemias

Korea, Republic of

3

Subscribe